M
Maat Pharma SA
PAR:MAAT
Maat Pharma SA
PAR:MAAT
Price:
5.68
EUR
Market Closed
Market Cap:
€106.9m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
M
|
Maat Pharma SA
PAR:MAAT
|
FR |
|
E
|
Edil San Felice SpA Societa Benefit
MIL:ESF
|
IT |
|
Thales SA
PAR:HO
|
FR |
|
Hanmi Financial Corp
NASDAQ:HAFC
|
US |
|
M
|
MKH Oil Palm East Kalimantan Bhd
KLSE:MKHOP
|
MY |
|
N
|
Nesco Ltd
NSE:NESCO
|
IN |
|
Kemira Oyj
F:KEM
|
FI |
|
DCM Corp
KRX:024090
|
KR |
|
Shenzhen Comix Group Co Ltd
SZSE:002301
|
CN |
|
N
|
National Instruments Corp
F:NI1
|
US |
|
Lithium Australia NL
ASX:LIT
|
AU |
|
Econ Healthcare (Asia) Ltd
SGX:EHG
|
SG |
|
S
|
South Jersey Industries Inc
F:J4S
|
US |
|
Cuckoo Homesys Co Ltd
KRX:284740
|
KR |
|
H
|
Hosiden Corp
SWB:HOD
|
JP |
|
T
|
Topcon Corp
OTC:TOPCF
|
JP |
|
N
|
Nurminen Logistics Oyj
OMXH:NLG1V
|
FI |
|
Amdocs Ltd
NASDAQ:DOX
|
US |
|
T
|
Tibet Duo Rui Pharmaceutical Co Ltd
SZSE:301075
|
CN |
|
Ackermans & Van Haaren NV
XBRU:ACKB
|
BE |
|
Mind Gym PLC
LSE:MIND
|
UK |
|
P
|
Petrovietnam Transportation Corp
VN:PVT
|
VN |
|
S
|
Sunny Loan Top Co Ltd
SSE:600830
|
CN |
|
T
|
TeamViewer SE
XBER:TMV
|
DE |
Cash Flow Statement
Cash Flow Statement
Maat Pharma SA
Maat Pharma SA
Currency: EUR
| Jun-2022 | Dec-2022 | Jun-2023 | Dec-2023 | Jun-2024 | Dec-2024 | Jun-2025 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | |||||||||
| Net Income |
(12)
|
(14)
|
(15)
|
(20)
|
(24)
|
(29)
|
(31)
|
(31)
|
|
| Depreciation & Amortization |
0
|
0
|
0
|
1
|
2
|
2
|
2
|
2
|
|
| Stock-Based Compensation |
1
|
1
|
1
|
1
|
1
|
2
|
2
|
2
|
|
| Other Non-Cash Items |
1
|
1
|
1
|
1
|
1
|
2
|
2
|
3
|
|
| Cash Interest Paid |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Change in Working Capital |
0
|
(0)
|
(5)
|
(0)
|
3
|
3
|
3
|
11
|
|
| Cash from Operating Activities |
(11)
N/A
|
(13)
-17%
|
(18)
-46%
|
(19)
-1%
|
(19)
-2%
|
(22)
-16%
|
(24)
-10%
|
(16)
+35%
|
|
| Investing Cash Flow | |||||||||
| Capital Expenditures |
(0)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
|
| Other Items |
(0)
|
(0)
|
0
|
1
|
0
|
0
|
0
|
0
|
|
| Cash from Investing Activities |
(0)
N/A
|
(1)
-256%
|
(1)
-15%
|
(0)
+53%
|
(0)
+55%
|
(0)
-108%
|
(0)
-18%
|
(0)
+45%
|
|
| Financing Cash Flow | |||||||||
| Net Issuance of Common Stock |
32
|
(0)
|
13
|
13
|
17
|
17
|
12
|
21
|
|
| Net Issuance of Debt |
2
|
6
|
5
|
(4)
|
(2)
|
2
|
(4)
|
0
|
|
| Other |
(0)
|
(0)
|
(1)
|
(0)
|
(0)
|
(0)
|
0
|
(0)
|
|
| Cash from Financing Activities |
34
N/A
|
5
-84%
|
16
+197%
|
8
-49%
|
15
+86%
|
18
+21%
|
9
-53%
|
21
+141%
|
|
| Change in Cash | |||||||||
| Net Change in Cash |
23
N/A
|
(8)
N/A
|
(3)
+57%
|
(11)
-218%
|
(4)
+63%
|
(4)
-2%
|
(16)
-292%
|
5
N/A
|
|
| Free Cash Flow | |||||||||
| Free Cash Flow |
(11)
N/A
|
(13)
-23%
|
(20)
-48%
|
(20)
-1%
|
(20)
+0%
|
(23)
-16%
|
(25)
-10%
|
(16)
+35%
|
|
Switch to:
Switch to:
See Also
Discover More
